论文部分内容阅读
目的探讨腺苷注射液和普罗帕酮转复室上性心动过速的临床疗效及安全性。方法85例室上速患者,随机分为腺苷组42例,普罗帕酮组43例,应用心电图、心电监护观察两组转复室上速的疗效。结果腺苷组转复成功例数88%,普罗帕酮组转复成功例数74%,P>0.05;转复时间腺苷组为36.5±16.4秒,普罗帕酮组为1562.8±625.6秒,P<0.001。结论腺苷注射液治疗室上性心动过速较普罗帕酮组更安全、有效。
Objective To investigate the clinical efficacy and safety of adenosine injection and propafenone in the recovery of supraventricular tachycardia. Methods A total of 85 cases of supraventricular tachycardia were randomly divided into adenosine group (n = 42) and propafenone group (n = 43). ECG and ECG were used to observe the effect of supraventricular tachycardia. Results The success rate of adenosine group was 88%, that of propafenone group was 74%, P> 0.05. The time of recovery time was 36.5 ± 16.4 seconds in adenosine group and 1562.8 ± 625.6 seconds in propafenone group, P <0.001. Conclusions Adenosine injection is more safe and effective than propafenone in the treatment of supraventricular tachycardia.